Hytrin ® (terazosin hydrochloride) is a selective alpha-1-receptor antagonist used for treatment of symptoms of prostate enlargement, benign prostatic hyperplasia (BPH). It also acts to lower the blood pressure.
Hytrin was first launched in the mid 1980s and is now available worldwide.
